Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
43.28 USD | -1.28% | +8.49% | +17.15% |
May. 07 | Halozyme Therapeutics Q1 Non-GAAP Earnings, Revenue Rise; 2024 Guidance Reaffirmed | MT |
May. 07 | Transcript : Halozyme Therapeutics, Inc., Q1 2024 Earnings Call, May 07, 2024 |
- Stock Market
- Equities
- HALO Stock
- News Halozyme Therapeutics, Inc.